Kate L Seib, Basil Donovan, Caroline Thng, David A Lewis, Anna McNulty, Christopher K Fairley, Barbara Yeung, Fengyi Jin, Doug Fraser, Benjamin R Bavinton, Matthew Law, Marcus Y Chen, Eric P F Chow, David M Whiley, Brent Mackie, Michael P Jennings, Amy V Jennison, Monica M Lahra, Andrew E Grulich
INTRODUCTION: Gonorrhoea, the sexually transmissible infection caused by Neisseria gonorrhoeae , has a substantial impact on sexual and reproductive health globally with an estimated 82 million new infections each year worldwide. N. gonorrhoeae antimicrobial resistance continues to escalate, and disease control is largely reliant on effective therapy as there is no proven effective gonococcal vaccine available. However, there is increasing evidence from observational cohort studies that the serogroup B meningococcal vaccine four-component meningitis B vaccine (4CMenB) (Bexsero), licensed to prevent invasive disease caused by Neisseria meningitidis , may provide cross-protection against the closely related bacterium N...
April 16, 2024: BMJ Open